Chronic obstructive pulmonary disease: Pulmonary function and CT lung attenuation do not show linear correlation

Radiology

Volumn 276, Issue 2, 2015, Pages 571-578

  Paoletti, Matteo ^a   Cestelli, Lucia ^a   Bigazzi, Francesca ^a   Camiciottoli, Gianna ^a   Pistolesi, Massimo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CARBON MONOXIDE LUNG DIFFUSING CAPACITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INHALATION; LUNG ATTENUATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION ATTENUATION; RESPIRATORY TRACT PARAMETERS; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RADIOGRAPHY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938702987     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015141769     Document Type: Article

References (35)

1. Lynch DA, Al-Qaisi MA. Quantitative computed tomography in chronic obstructive pulmonary disease. J Thorac Imaging 2013;28(5):284-290.
2. Litmanovich DE, Hartwick K, Silva M, Bankier AA. Multidetector computed tomographic imaging in chronic obstructive pulmonary disease: emphysema and airways assessment. Radiol Clin North Am 2014;52(1):137-154.
3. Hayhurst MD, MacNee W, Flenley DC, et al. Diagnosis of pulmonary emphysema by computerised tomography. Lancet 1984;2(8398):320-322.
4. Müller NL, Staples CA, Miller RR, Abboud RT. "Density mask:" an objective method to quantitate emphysema using computed tomography. Chest 1988;94(4):782-787.
5. Knudson RJ, Standen JR, Kaltenborn WT, et al. Expiratory computed tomography for assessment of suspected pulmonary emphysema. Chest 1991;99(6):1357-1366.
6. Miniati M, Filippi E, Falaschi F, et al. Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease: chest radiography versus high resolution computed tomography. Am J Respir Crit Care Med 1995;151(5):1359-1367.
7. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152(2):653-657.
8. Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996;154(1):187-192.
9. Gevenois PA, De Vuyst P, Sy M, et al. Pulmonary emphysema: quantitative CT during expiration. Radiology 1996;199(3):825-829.
10. Kinsella M, Müller NL, Abboud RT, Morrison NJ, DyBuncio A. Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests. Chest 1990;97(2):315-321.
11. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: correlation with lung function. Am J Respir Crit Care Med 2000;162(3 Pt 1):1102-1108.
12. Camiciottoli G, Bartolucci M, Maluccio NM, et al. Spirometrically gated high-resolution CT findings in COPD: lung attenuation vs lung function and dyspnea severity. Chest 2006;129(3):558-564.
13. Xie X, de Jong PA, Oudkerk M, et al. Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: systematic review and metaanalysis. Eur Radiol 2012;22(10):2085-2093.
14. Schroeder JD, McKenzie AS, Zach JA, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol 2013;201(3):W460-W470.
15. Hogg JC, Wright JL, Wiggs BR, Coxson HO, Opazo Saez A, Paré PD. Lung structure and function in cigarette smokers. Thorax 1994;49(5):473-478.
16. Gelb AF, Hogg JC, Müller NL, et al. Contribution of emphysema and small airways in COPD. Chest 1996;109(2):353-359.
17. Bhatt SP, Sieren JC, Dransfield MT, et al. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax 2014;69(5):410-415.
18. Cerveri I, Dore R, Corsico A, et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest 2004;125(5):1714-1718.
19. Desai SR, Hansell DM, Walker A, MacDonald SL, Chabat F, Wells AU. Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent. Eur Radiol 2007;17(4):911-918.
20. Hesselbacher SE, Ross R, Schabath MB, et al. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health 2011;8(5):1324-1340.
21. Karimi R, Tornling G, Forsslund H, et al. Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers. Respir Res 2014;15:23.
22. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.gold-copd.org/. Published 2014. Accessed June 26, 2014.
23. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
24. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26(3):511-522.
25. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720-735.
26. Cherkassky V, Ma Y. Multiple model regression estimation. IEEE Trans Neural Netw 2005;16(4):785-798.
27. Anscombe FJ. Graphs in statistical analysis. Am Stat 1973;27(1):17-21.
28. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
29. Wedzicha JA. The heterogeneity of chronic obstructive pulmonary disease. Thorax 2000;55(8):631-632.
30. Pistolesi M. Beyond airflow limitation: another look at COPD. Thorax 2009;64(1):2-4.
31. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182(5):598-604.
32. Casanova C, de Torres JP, Aguirre-Jaíme A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med 2011;184(9):1015-1021.
33. Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest 2011;140(3):634-642.
34. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008;31(4):869-873.
35. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7(1):32-43.